Table 3.
Series | Platform | Country/Region | Citation | Number of samples | miR-196b-5p expression (Mean ± SD) | ||
---|---|---|---|---|---|---|---|
HCC | Normal control | HCC | Normal control | ||||
GSE6857 | GPL4700 | USA | Budhu et al. (2008) | 241 | 241 | 10.322±0.607 | 10.113±0.575 |
GSE12717 | GPL7274 | USA | Su et al. (2009) | 10 | 6 | 4.742±0.629 | 3.987±0.544 |
GSE21362 | GPL10312 | Japan | Sato et al. (2011) | 73 | 73 | 1.686±1.463 | 1.053±0.957 |
GSE22058 | GPL10457, GPL6793, GPL9733 | USA | Burchard et al. (2010) | 96 | 96 | 0.416±0.214 | 0.265±0.020 |
GSE31383 | GPL10122 | USA | Wang et al. (2012) | 9 | 10 | 1.084±1.584 | 0.223±0.081 |
GSE41874 | GPL7722 | Japan | None | 3 | 3 | 1.171±0.129 | 1.359±0.397 |
GSE54751 | GPL18262 | USA | Shen et al. (2015) | 9 | 10 | 1.002±0.002 | 1.000±0.000 |
GSE57555 | GPL18044, GPL16699 | Japan | Murakami et al. (2015) | 5 | 16 | 0.975±0.004 | 0.969±0.015 |
GSE69580 | GPL10850 | Taiwan | None | 5 | 5 | 2.938±1.832 | 0.824±0.527 |
GSE74618 | GPL14613 | Spain | Villanueva et al. (2016) | 218 | 10 | 1.380±0.483 | 1.227±0.158 |
Note: HCC, hepatocellular carcinoma; USA, United States of America; SMD, standard mean difference.